Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EU CHMP Opinions And MAA Updates

31 Jan 2024

• By Neena Brizmohun

EU CHMP Opinions and MAA Updates — • Source: Pink Sheet/Shutterstock

Related Content

EMA Thumbs Up For Idorsia’s Insomnia Drug And Immunocore’s Uveal Melanoma Treatment

25 Feb 2022

EMA Gives Oncopeptides’ Multiple Myeloma Drug The Thumbs Up; Keeps US FDA In Loop

24 Jun 2022

BioMarin’s Hemophilia Gene Therapy Among Nine Products On Track For EU-Wide Approval

24 Jun 2022

Valneva Wins EU Nod For COVID-19 Vaccine

23 Jun 2022

EMA Turns Down Minoryx’s Orphan Drug Nezglyal & Apellis’ Syfovre, OKs Three Others

26 Jan 2024

EMA Considers Cardiovascular Indication & Extra Market Protection For Wegovy

23 Jan 2024

Sanofi & GSK Win COVID-19 Vaccine Approval In EU Using Immunobridging Trials

11 Nov 2022

EU Filing For Infigratinib Pulled After Commercial Deal Crumbles

07 Nov 2022

Lilly Pulls EU Approval Application For Olumiant In COVID-19

19 Dec 2022

Hemophilia B Gene Therapy Among Five Drugs On Track For EU-Wide Approval

16 Dec 2022

Janssen’s Multiple Myeloma Gene Therapy On Track For EU-Wide Approval

25 Mar 2022

Marketing Firsts Due As Amryt’s Filsuvez And Roche’s Lunsumio Win EU Nod

25 Apr 2022

Biogen Pulls EU Filing For Aduhelm But Stands By Alzheimer’s Drug

22 Apr 2022

Dengue Vaccine Qdenga & Nine Drugs Win EMA Thumbs Up

17 Oct 2022

First Gene Editing Therapy Among Seven Drugs On Track For EU-Wide Approval

15 Dec 2023

EMA Thumbs Up For HyQvia As Maintenance Therapy For Rare Neurological Disorder

18 Dec 2023

EMA OKs Seven New Drugs Including First RSV Vaccine For Older Adults

27 Apr 2023

AstraZeneca/Daiichi Sankyo’s Enhertu To Get Lung Cancer Label For EU

18 Sep 2023

Lebrikizumab Among Nine Drugs To Get EMA Nod; PTC Faces Disappointment For Translarna

15 Sep 2023

AbbVie’s Aquipta & GSK’s Jesduvroq Move Closer To EU Market

23 Jun 2023

Amylyx To Appeal Against EMA Rejection Of ALS Drug Albrioza

23 Jun 2023

EMA Says Yes To GSK’s Omjjara, UCB’s Rystiggo and Novartis’ Spexotras

10 Nov 2023

Success For Mirati As EMA Backs Krazati For EU Approval After Initial Rejection

13 Nov 2023

EMA Backs Approval For Eight New Drugs But Rejects Lagevrio For COVID-19

24 Feb 2023

EMA ‘Extremely Collaborative And Well Prepared’ During Review Of Santhera’s DMD Drug Agamree

16 Oct 2023

EMA Backs Approval Of Santhera’s Agamree, Pfizer’s Elrexfio & Several Other New Drugs

13 Oct 2023

Bad News For Amylyx As EMA Upholds Rejection Of ALS Drug Albrioza

13 Oct 2023

Mirati To Challenge EMA’s Rejection Of US-Approved Krazati

21 Jul 2023

EMA Says Yes To Janssen’s Talvey & 13 Other Drugs

21 Jul 2023

SK Bioscience Pulls EU Filing For COVID Jab As Regulators Shift Focus To XBB Vaccines

15 Sep 2023

ERC Not Giving Up On Glioma Immunotherapy In EU

23 May 2022

PTC’s ‘Life-Changing’ Gene Therapy Among Nine Drugs To Win EU Thumbs Up

20 May 2022

Kite Wins EMA Recommendation To Market Tecartus For Leukemia Patients

25 Jul 2022

Janssen’s Multiple Myeloma Drug Among 11 Products To Get EMA Thumbs Up

22 Jul 2022

Ophthalmic Bevacizumab Sponsor Not Giving Up On EMA Rejection

28 Jan 2022

BMS’ Cell Therapy For Lymphoma On Track For EU-Wide Approval

28 Jan 2022

EMA OKs First Drug To Prevent RSV Infection In Babies

16 Sep 2022

EMA Says Yes To BMS’ Sotyktu But Turns Down Ipsen’s Sohonos

27 Jan 2023

Lilly’s Omvoh Among Nine New Drugs Securing EU Marketing Thumbs Up

31 Mar 2023

Additional Topics

Europe Drug Review Regulation Approvals Review Pathway BioPharmaceutical European Performance Tracker

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.